Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Change in Acquisitions & Divestments: 2011-2025

Historic Change in Acquisitions & Divestments for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Sep 2025 value amounting to $689.6 million.

  • Arrowhead Pharmaceuticals' Change in Acquisitions & Divestments rose 8.59% to $101.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $689.6 million, marking a year-over-year increase of 55.90%. This contributed to the annual value of $689.6 million for FY2025, which is 55.90% up from last year.
  • According to the latest figures from FY2025, Arrowhead Pharmaceuticals' Change in Acquisitions & Divestments is $689.6 million, which was up 55.90% from $442.3 million recorded in FY2024.
  • In the past 5 years, Arrowhead Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $689.6 million in FY2025 and a low of $122.6 million during FY2021.
  • In the last 3 years, Arrowhead Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $442.3 million in 2024 and averaged $486.2 million.
  • Data for Arrowhead Pharmaceuticals' Change in Acquisitions & Divestments shows a peak YoY spiked of 144.51% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Arrowhead Pharmaceuticals' Change in Acquisitions & Divestments stood at $122.6 million in 2021, then soared by 120.86% to $270.8 million in 2022, then grew by 20.67% to $326.7 million in 2023, then surged by 35.39% to $442.3 million in 2024, then spiked by 55.90% to $689.6 million in 2025.